ATE287898T1 - Parathyroid-hormon-rezeptor und seine kodierende dna - Google Patents
Parathyroid-hormon-rezeptor und seine kodierende dnaInfo
- Publication number
- ATE287898T1 ATE287898T1 AT92910874T AT92910874T ATE287898T1 AT E287898 T1 ATE287898 T1 AT E287898T1 AT 92910874 T AT92910874 T AT 92910874T AT 92910874 T AT92910874 T AT 92910874T AT E287898 T1 ATE287898 T1 AT E287898T1
- Authority
- AT
- Austria
- Prior art keywords
- parathyroid hormone
- hormone receptor
- acid sequence
- compound
- amino acid
- Prior art date
Links
- 102000006461 Parathyroid Hormone Receptors Human genes 0.000 title abstract 3
- 108010058828 Parathyroid Hormone Receptors Proteins 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 2
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 2
- 102000043299 Parathyroid hormone-related Human genes 0.000 abstract 2
- 101710123753 Parathyroid hormone-related protein Proteins 0.000 abstract 2
- 239000000199 parathyroid hormone Substances 0.000 abstract 2
- 229960001319 parathyroid hormone Drugs 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 208000037147 Hypercalcaemia Diseases 0.000 abstract 1
- 208000013038 Hypocalcemia Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000000148 hypercalcaemia Effects 0.000 abstract 1
- 208000030915 hypercalcemia disease Diseases 0.000 abstract 1
- 230000000705 hypocalcaemia Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/30—Bird
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/046—Thyroid disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Plant Pathology (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68170291A | 1991-04-05 | 1991-04-05 | |
PCT/US1992/002821 WO1992017602A1 (en) | 1991-04-05 | 1992-04-06 | Parathyroid hormone receptor and dna encoding same |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE287898T1 true ATE287898T1 (de) | 2005-02-15 |
Family
ID=24736412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92910874T ATE287898T1 (de) | 1991-04-05 | 1992-04-06 | Parathyroid-hormon-rezeptor und seine kodierende dna |
Country Status (7)
Country | Link |
---|---|
US (2) | US5494806A (de) |
EP (2) | EP1586641A3 (de) |
JP (3) | JP3464796B2 (de) |
AT (1) | ATE287898T1 (de) |
CA (1) | CA2107569C (de) |
DE (1) | DE69233472T2 (de) |
WO (1) | WO1992017602A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5261686A (en) * | 1992-04-06 | 1993-11-16 | Buckler Clive E | Semi-recumbent |
ATE287898T1 (de) * | 1991-04-05 | 2005-02-15 | Gen Hospital Corp | Parathyroid-hormon-rezeptor und seine kodierende dna |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
EP0832123A4 (de) * | 1995-06-05 | 1999-12-22 | Human Genome Sciences Inc | Parathyroidrezeptor hltdg74 gekoppelt an ein g-protein |
US6030804A (en) | 1995-06-06 | 2000-02-29 | Human Genome Sciences, Inc. | Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74 polypeptides |
US5660826A (en) * | 1995-06-06 | 1997-08-26 | The Regents Of The University Of California | Therapeutic sepsis treatment using antagonists to PTHrP |
WO1997039131A1 (en) * | 1996-04-15 | 1997-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |
WO1998004591A1 (en) * | 1996-07-31 | 1998-02-05 | The General Hospital Corporation | Novel parathyroid hormone-related peptide analogs |
HUP9904177A3 (en) | 1996-09-26 | 2001-10-29 | Chugai Pharmaceutical Co Ltd | Antibody against human parathormone related peptides |
JP3459523B2 (ja) * | 1996-10-02 | 2003-10-20 | 賢二 坂本 | 生理活性物質の製造方法 |
US6077949A (en) * | 1996-12-13 | 2000-06-20 | Allelix Biopharmaceuticals, Inc. | Cloned glucagon-like peptide 2 receptors |
US7473537B1 (en) | 1996-12-13 | 2009-01-06 | Nps Pharmaceuticals, Inc. | Cloned glucagon-like peptide-2 receptors |
US8592553B2 (en) | 1996-12-13 | 2013-11-26 | Nps Pharmaceuticals, Inc. | Cloned glucagon-like peptide-2 receptors |
EP1004313B1 (de) | 1997-05-15 | 2007-05-02 | Chugai Seiyaku Kabushiki Kaisha | Heilmittel für kachexie |
US6183974B1 (en) * | 1997-07-31 | 2001-02-06 | The General Hospital Corporation | Screening assays for G protein coupled receptor agonists and antagonists |
US6107287A (en) * | 1997-09-25 | 2000-08-22 | The Regents Of The University Of California | Lunasin peptides |
JP2002513570A (ja) * | 1998-05-01 | 2002-05-14 | インサイト・ファーマスーティカルズ・インコーポレイテッド | ヒト受容体分子 |
US6720153B1 (en) | 1998-09-04 | 2004-04-13 | Aventis Pharmaceuticals Inc. | Luciferase reporter bioassay of parathyroid hormone compounds |
ATE290214T1 (de) * | 1998-09-04 | 2005-03-15 | Aventis Pharma Inc | Luciferase-reporter-testverfahren für parathyroidhormon-verbindungen |
JP4486256B2 (ja) * | 1998-10-22 | 2010-06-23 | ザ・ジェネラル・ホスピタル・コーポレイション | 副甲状腺ホルモン(PTH)および副甲状腺ホルモン関連ペプチド(PTHrP)の生物活性ペプチドおよびペプチド誘導体 |
AU4217299A (en) | 1998-11-30 | 2000-06-19 | General Hospital Corporation, The | Pth1r and pth3r receptors, methods and uses thereof |
AU2023499A (en) * | 1998-12-31 | 2000-07-24 | General Hospital Corporation, The | Pth receptor and screening assay utilizing the same |
AU5708500A (en) * | 1999-07-02 | 2001-01-22 | Chugai Seiyaku Kabushiki Kaisha | Remedies for diseases caused by pth or pthrp |
TWI255718B (en) | 1999-07-02 | 2006-06-01 | Chugai Pharmaceutical Co Ltd | Ameliorative agent for low vasopressin concentration |
PL353407A1 (en) * | 1999-07-06 | 2003-11-17 | Chugai Seiyaku Kabushiki Kaisha | Remedies for drug-resistant hypercalcemia |
WO2001023521A2 (en) * | 1999-09-29 | 2001-04-05 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (pth) |
DE10014690A1 (de) * | 2000-03-24 | 2001-10-18 | Franz Wolfgang M | Verfahren zur Isolierung in vito differenzierter Körperzellen |
US6756480B2 (en) * | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
US20050124537A1 (en) * | 2000-04-27 | 2005-06-09 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
WO2001082968A1 (fr) | 2000-04-28 | 2001-11-08 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de proliferation cellulaire |
EP1439854B1 (de) | 2001-07-23 | 2016-12-14 | The General Hospital Corporation | Parathormon (pth)-analoga mit beschränkter konformation |
JP5314234B2 (ja) * | 2002-11-29 | 2013-10-16 | アールエスアール リミテッド | チロトロピン受容体の結合対象及びその使用 |
WO2004073587A2 (en) * | 2003-02-19 | 2004-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 1 (pthr1) |
WO2004093902A1 (en) * | 2003-03-19 | 2004-11-04 | The General Hospital Corporation | CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH α-HELIX STABILIZERS |
JP4871128B2 (ja) * | 2003-07-17 | 2012-02-08 | ザ ジェネラル ホスピタル コーポレイション | 高次構造的に制約された副甲状腺ホルモン(pth)アナログ |
EP2054077A4 (de) * | 2006-08-04 | 2010-10-13 | Gen Hospital Corp | Polypeptidderivate des parathyroidhormons (pth) |
WO2009017809A2 (en) | 2007-08-01 | 2009-02-05 | The General Hospital Corporation | Screening methods using g-protein coupled receptors and related compositions |
WO2011143406A2 (en) | 2010-05-13 | 2011-11-17 | The General Hospital Corporation | Parathyroid hormone analogs and uses thereof |
CA2951390C (en) * | 2014-06-18 | 2024-02-13 | Toray Industries, Inc. | Esophageal cancer detection kit or device, and detection method |
RU2771328C2 (ru) * | 2016-06-23 | 2022-04-29 | Титон Биотек, Инк. | Клетки, экспрессирующие рецептор паратиреоидного гормона 1, и их применение |
CN107622184B (zh) * | 2017-09-29 | 2020-01-21 | 中国科学院计算技术研究所 | 氨基酸可信度和修饰位点定位的评估方法 |
EP3765061A4 (de) | 2018-03-16 | 2022-01-26 | The General Hospital Corporation | Parathormon-polypeptidkonjugate und verfahren zu deren verwendung |
BR112021011566A2 (pt) * | 2019-01-11 | 2021-08-31 | Radius Health, Inc. | Métodos para detecção de anticorpos neutralizantes para hormônio de paratiroide (pth) e análogo de peptídeo relacionado a hormônio de paratiroide (pthrp) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740463A (en) * | 1984-04-13 | 1988-04-26 | Massachusetts Institute Of Technology | Methods and artificial genes for antagonizing the function of an oncogene |
US4736866B1 (en) * | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
US5217896A (en) * | 1988-12-30 | 1993-06-08 | Oncogene Science, Inc. | Monoclonal antibodies recognizing parathyroid hormone-like protein |
ATE287898T1 (de) * | 1991-04-05 | 2005-02-15 | Gen Hospital Corp | Parathyroid-hormon-rezeptor und seine kodierende dna |
ATE175241T1 (de) * | 1992-04-03 | 1999-01-15 | Genentech Inc | Antikörper gegen alpha v beta 3 integrin |
US5660826A (en) * | 1995-06-06 | 1997-08-26 | The Regents Of The University Of California | Therapeutic sepsis treatment using antagonists to PTHrP |
-
1992
- 1992-04-06 AT AT92910874T patent/ATE287898T1/de not_active IP Right Cessation
- 1992-04-06 WO PCT/US1992/002821 patent/WO1992017602A1/en active IP Right Grant
- 1992-04-06 JP JP51003592A patent/JP3464796B2/ja not_active Expired - Lifetime
- 1992-04-06 EP EP04078272A patent/EP1586641A3/de not_active Withdrawn
- 1992-04-06 DE DE69233472T patent/DE69233472T2/de not_active Expired - Lifetime
- 1992-04-06 CA CA2107569A patent/CA2107569C/en not_active Expired - Lifetime
- 1992-04-06 US US07/864,475 patent/US5494806A/en not_active Expired - Lifetime
- 1992-04-06 EP EP92910874A patent/EP0579758B1/de not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/471,494 patent/US5840853A/en not_active Expired - Lifetime
-
2003
- 2003-06-13 JP JP2003170024A patent/JP2004121225A/ja not_active Withdrawn
-
2009
- 2009-08-17 JP JP2009188644A patent/JP4790836B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69233472T2 (de) | 2006-02-09 |
JP2010004889A (ja) | 2010-01-14 |
EP0579758A4 (en) | 1995-11-02 |
JP3464796B2 (ja) | 2003-11-10 |
WO1992017602A1 (en) | 1992-10-15 |
US5494806A (en) | 1996-02-27 |
US5840853A (en) | 1998-11-24 |
EP1586641A3 (de) | 2008-04-09 |
JPH06506598A (ja) | 1994-07-28 |
JP4790836B2 (ja) | 2011-10-12 |
DE69233472D1 (de) | 2005-03-03 |
JP2004121225A (ja) | 2004-04-22 |
CA2107569C (en) | 2011-08-02 |
EP1586641A2 (de) | 2005-10-19 |
CA2107569A1 (en) | 1992-10-06 |
EP0579758A1 (de) | 1994-01-26 |
EP0579758B1 (de) | 2005-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE287898T1 (de) | Parathyroid-hormon-rezeptor und seine kodierende dna | |
Brandt et al. | All major lung cancer cell types produce parathyroid hormone-like protein: heterogeneity assessed by high performance liquid chromatography | |
DE69634726D1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
DK150992A (da) | Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor | |
DE60043626D1 (de) | Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2 | |
BR9007921A (pt) | Sequencia de dna codificando para um derivado de fator viii humano,recombinante biologicamente ativo,vetor de expressao recombinante,cellula haspedeira de origem animal,processo para a fabricacao de um derivado e derivado de fator viii humano | |
DK521386D0 (da) | Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden | |
DE69005620T2 (de) | Polypeptide mit einer aktivität des menschlichen beta-andrenergischen rezeptors, einbezogen in die lipolytische antwort, deren nukleinsäuresequenzen. | |
ATE123949T1 (de) | B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung. | |
DE3786649D1 (de) | Pferde-gamma-interferon. | |
ES555124A0 (es) | Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas | |
ATE432287T1 (de) | Peptidfragmente mit den zelltod verhindernder aktivität | |
DE3481386D1 (de) | Bestimmung von fibrin mit fibrin-spezifischen antikoerpern. | |
DE68918323T2 (de) | Spezifische Spaltung von Peptidbindungen durch organische tertiäre Phosphine mit nukleophilen Seitenketten. | |
EP0035454A3 (de) | Desacetyl-thymosin-alpha-1, Verfahren zu dessen Herstellung und dessen Verwendung | |
DK0555785T3 (da) | Glat-muskel-mitogent stof og DNA, der koder herfor | |
Chang et al. | Isolation and properties of sea turtle (Chelonia mydas) pituitary prolactin | |
Hale et al. | Quantitation of cysteine residues alkylated with 3-bromopropylamine by amino acid analysis | |
DK0572088T3 (da) | Modificerede signalsekvenser | |
DE60138885D1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
ES2074087T3 (es) | Peptido-señal y secuencias de adn que codifican para el mismo. | |
EP1308512A4 (de) | Neuartige proteine und deren dna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |